Tolperisone hydrochloride is a centrally acting skeletal muscle relaxant used therapeutically to treat spastic paralysis, muscular dystonia, and pathologically increased skeletal muscle tone resulting… Read more
Tolperisone hydrochloride is a centrally acting skeletal muscle relaxant used therapeutically to treat spastic paralysis, muscular dystonia, and pathologically increased skeletal muscle tone resulting from neurological conditions and various encephalopathies. To ensure the safety and efficacy of this medication, pharmaceutical laboratories rely on high-quality reference standards for analytical testing, method validation, and quality control. This collection provides access to essential compounds, including related impurities, identified metabolites such as carboxylic acid derivatives, and stable isotope labelled versions of the drug. These materials are fundamental to precise impurity profiling, allowing researchers to detect and quantify trace impurities or track metabolic pathways during stability studies. By using these rigorously characterized standards, laboratories can maintain rigorous regulatory compliance and uphold rigorous analytical standards in the characterization of pharmaceutical products throughout the development and manufacturing lifecycle.
